de.mpg.escidoc.pubman.appbase.FacesBean
Deutsch
 
Hilfe Wegweiser Impressum Kontakt Einloggen
  DetailsucheBrowse

Datensatz

DATENSATZ AKTIONENEXPORT

Freigegeben

Vortrag

N-glycan analysis method for cell culture derived influenza virus hemagglutinin

MPG-Autoren
http://pubman.mpdl.mpg.de/cone/persons/resource/persons86475

Schwarzer,  J.
Bioprocess Engineering, Max Planck Institute for Dynamics of Complex Technical Systems, Max Planck Society;

http://pubman.mpdl.mpg.de/cone/persons/resource/persons86442

Rapp,  E.
Physical and Chemical Foundations of Process Engineering, Max Planck Institute for Dynamics of Complex Technical Systems, Max Planck Society;

http://pubman.mpdl.mpg.de/cone/persons/resource/persons86448

Reichl,  U.
Otto-von-Guericke-Universität Magdeburg;
Bioprocess Engineering, Max Planck Institute for Dynamics of Complex Technical Systems, Max Planck Society;

Externe Ressourcen
Es sind keine Externen Ressourcen verfügbar
Volltexte (frei zugänglich)
Es sind keine frei zugänglichen Volltexte verfügbar
Ergänzendes Material (frei zugänglich)
Es sind keine frei zugänglichen Ergänzenden Materialien verfügbar
Zitation

Schwarzer, J., Rapp, E., & Reichl, U. (2007). N-glycan analysis method for cell culture derived influenza virus hemagglutinin. Talk presented at Joint Meeting 2007. Lille, France. 2007-11-04 - 2007-11-06.


Zitierlink: http://hdl.handle.net/11858/00-001M-0000-0013-9701-C
Zusammenfassung
The influenza A virus envelope protein HA is glycosylated by 3 to 9 N-linked glycans, depending on the virus strain. Thereby the glycosylation pattern is affected by the glycosylation machinery of the host cell and their cultivation conditions. Further modifications in the structure can occur during inactivation and downstream processing steps. Hence, monitoring HA glycosylation pattern in virus production processes can be used e.g. as a tool to ensure the immunogenicity of the antigens. In this study, a sensitive and reproducible N-glycan profiling method for cell culture derived influenza virus HA is presented. We are able to monitoring potential variations of the glycosylation pattern, concerning N-glycan type and amount, due to the production process. The method includes virus purification directly from cell culture supernatant, protein separation by SDS-PAGE, endo- and exoglycosidase-cleavage of N-glycans, desalting and Capillary gel electrophoresis (CGE-LIF). HA N-glycan fingerprints from influenza virus produced in different host cell systems and different influenza virus strains and subtypes are compared. Glycan structures were analysed by spiking glycans of known structures and sequential exoglycosidase digestion. The developed method presents a promising tool to characterize and compare N-glycosylation patterns of HA during the major steps of up- and downstream processing in influenza virus vaccine production.